Jacobs Levy Equity Management, Inc Infinity Pharmaceuticals, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.49 - $1.2 $11,542 - $28,268	-23,557 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.86 - $3.36 $100,864 - $182,206	-54,228 Reduced 69.72%	23,557 $53,000
Q2 2021 Aug 16, 2021	SELL	$2.66 - $3.47 $611,129 - $797,225	-229,748 Reduced 74.71%	77,785 $233,000
Q1 2021 May 17, 2021	BUY	$1.98 - $5.36 $327,054 - $885,359	165,179 Added 116.03%	307,533 $993,000
Q4 2020 Feb 16, 2021	SELL	$1.05 - $2.77 $141,955 - $374,492	-135,196 Reduced 48.71%	142,354 $302,000
Q2 2020 Aug 17, 2020	BUY	$0.77 - $1.13 $10,010 - $14,691	13,001 Added 4.91%	277,550 $251,000
Q1 2020 May 15, 2020	BUY	$0.69 - $1.52 $86,316 - $190,145	125,096 Added 89.7%	264,549 $222,000
Q4 2019 Feb 14, 2020	SELL	$0.88 - $1.29 $10,281 - $15,071	-11,683 Reduced 7.73%	139,453 $134,000
Q3 2019 Nov 14, 2019	SELL	$1.03 - $1.75 $51,811 - $88,028	-50,302 Reduced 24.97%	151,136 $156,000
Q2 2019 Aug 13, 2019	BUY	$1.43 - $1.87 $13,600 - $17,785	9,511 Added 4.96%	201,438 $363,000
Q1 2019 May 14, 2019	BUY	$1.18 - $1.91 $74,104 - $119,948	62,800 Added 48.63%	191,927 $361,000
Q4 2018 Feb 14, 2019	BUY	$1.01 - $2.78 $18,960 - $52,188	18,773 Added 17.01%	129,127 $152,000
Q3 2018 Nov 14, 2018	SELL	$1.72 - $2.71 $100,401 - $158,190	-58,373 Reduced 34.6%	110,354 $299,000
Q2 2018 Aug 14, 2018	SELL	$1.72 - $2.26 $77,572 - $101,925	-45,100 Reduced 21.09%	168,727 $322,000
Q1 2018 May 15, 2018	SELL	$1.8 - $2.74 $8,280 - $12,604	-4,600 Reduced 2.11%	213,827 $449,000
Q4 2017 Feb 13, 2018	BUY	$1.22 - $3.73 $145,058 - $443,497	118,900 Added 119.47%	218,427 $443,000
Q3 2017 Nov 14, 2017	SELL	$0.94 - $1.35 $239,102 - $343,391	-254,364 Reduced 71.88%	99,527 $132,000
Q2 2017 Nov 09, 2017	BUY	N/A	353,891	353,891 $556,000

Others Institutions Holding INFI

# of Institutions

Shares Held

1.26M

Call Options Held

Put Options Held

View Full List

About INFINITY PHARMACEUTICALS, INC.

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

More about INFI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account